ARCTURUS THERAPEUTICS HOLDINGS INC. Operating Lease, Liability, Noncurrent
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Operating Lease, Liability, Noncurrent of $18.97 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $18.97M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $19.68M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $20.78M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $21.86M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $18.97M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $19.68M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $20.78M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $21.86M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $22.93M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $23.99M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $25.00M 10-K · filed 2026-03-03 |
| 2024-09-30 | $25.99M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $26.96M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $27.65M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $25.91M 10-K · filed 2025-03-06 |
| 2023-09-30 | $27.02M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $28.11M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $29.19M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $30.22M 10-K · filed 2024-03-14 |
| 2022-09-30 | $31.22M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $32.20M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $4.06M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $4.50M 10-K · filed 2023-03-29 |
| 2021-09-30 | $4.93M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.36M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $5.71M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $4.03M 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.16M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $4.39M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.63M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $4.85M 10-K · filed 2021-03-01 |
| 2019-09-30 | $5.07M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $5.28M 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |